Bexamika 500 Injection
Marketer
Mcbrex Lifesciences
Salt Composition
Amikacin (500mg)
Overview Bexamika 500 Injection
Bexamika 500 Injection, an antibacterial medication, combats a broad spectrum of bacterial infections. These can affect various areas, including the urinary system, skeletal system, respiratory system (such as pneumonia), central nervous system, and circulatory system. Prophylactic use is also common in hospitalized individuals to prevent infection onset. Its mechanism involves inhibiting bacterial proliferation. Administration, strictly under medical supervision, occurs via intravenous infusion or direct injection (intravenous or intramuscular). Self-medication is strictly prohibited. Adherence to the prescribed dosage schedule, maintaining consistent intervals, is crucial. Complete the entire course, even with symptom improvement, as premature discontinuation risks recurrence or exacerbation. Typical adverse reactions encompass injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant medical consultation. High dosages may rarely induce vertigo, renal impairment, and auditory deficits. Strict adherence to physician instructions is paramount, potentially including routine monitoring of kidney function, hearing, and urine analysis. This medication is contraindicated during pregnancy. Disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Uses of Bexamika 500 Injection
Infections caused by bacteria
Major Benefits of Bexamika 500 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
Common Side effects of Bexamika 500 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Bexamika 500 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bexamika 500 Injection works:
Bexamika 500 Injection is a bacterial growth inhibitor, a type of antibiotic. Its mechanism of action involves blocking the production of vital bacterial proteins, thereby halting bacterial proliferation.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Bexamika 500 Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Bexamika 500 Injection during pregnancy is contraindicated due to established fetal risks. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
Bexamika 500 Injection poses no known breastfeeding safety concerns. Research in humans indicates minimal drug transfer into breast milk, presenting no apparent risk to the infant.
DrivingUNSAFE
Administering Bexamika 500 Injection might induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these side effects manifest.
KidneyCAUTION
Use of Bexamika 500 Injection requires careful consideration in individuals with impaired kidney function. Dosage modification for Bexamika 500 Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Bexamika 500 Injection in patients with hepatic impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Bexamika 500 Injection :
Should you inadvertently skip a dose of Bexamika 500 Injection, seek medical advice.
Facts to Know About Bexamika 500 Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently